Follow us on Twitter
twitter icon@FreshPatents

Sodium Citrate patents

Bulk PDF Downloads
      

This page is updated frequently with new Sodium Citrate-related patent applications.




 Additive compositions for low loss wire and cable dielectric and products obtained thereby patent thumbnailAdditive compositions for low loss wire and cable dielectric and products obtained thereby
There are disclosed additive compositions for polymer base materials, which additive compositions are comprised of blowing agent (direct gas or chemical blowing agent), thermoplastic polymer carrier for the chemical blowing agent and filler, wherein the thermoplastic polymer carrier has a melting point below the decomposition temperature of the chemical blowing agent. The additive compositions improve the dielectric properties of a foamed material and find particular application as additives for coverings for metallic or non-metallic conductive wire or cable composites.
Reedy International Corporation


 Broad spectrum pharmacological composition for treatmentof various infections and diseases and methodsof use patent thumbnailBroad spectrum pharmacological composition for treatmentof various infections and diseases and methodsof use
A pharmacological composition for the treatment of bacterial and protozoal infections in a patient. The preferred pharmacological composition comprises a pharmaceutical carrier and an active composition selected from the group consisting of: a) an amount of sodium oxalate and an amount of oxalic acid, b) an amount of sodium citrate and an amount of citric acid, or c) mixtures of a) and b).

 Paper pulping process and composition patent thumbnailPaper pulping process and composition
This is a method and composition for a paper pulp product used to create formable or moldable products from the paper pulp that cures with significant rigidity, stability and strength. The composition includes a mixture of raw paper, portland type 1, class c fly ash, hydrated lime, perlite polyvinyl alcohol and water.
Friends Of Abilities First, Inc.


 Citrate resorption of bone as a treatment for spinal stenosis patent thumbnailCitrate resorption of bone as a treatment for spinal stenosis
Spinal stenosis is a common debilitating illness that produces symptoms of neurogenic claudication, radiculopathy and weakness. Present therapies include administration of analgesics, epidural injections of local anesthetic with corticosteroids and decompression laminectomy.

 Methods of using hydrogen peroxide for in-situ chemical oxidation treatment of soil and groundwater patent thumbnailMethods of using hydrogen peroxide for in-situ chemical oxidation treatment of soil and groundwater
Disclosed are methods of custom stabilization of the hydrogen peroxide used in the safe in-situ treatment of soil and groundwater. In one embodiment, disclosed is a method of in-situ chemical oxidation treatment of soil and/or groundwater wherein the hydrogen peroxide has been stabilized with carboxylate salt (e.g., sodium citrate, sodium malonate, or sodium phytate).

 Methods and compositions for the disruption of biofilms and treatment of disorders characterized by the presence of biofilms patent thumbnailMethods and compositions for the disruption of biofilms and treatment of disorders characterized by the presence of biofilms
Methods and compositions are provided for the disruption of biofilms and the treatment of disorders characterized by the presence of biofilms and/or abnormally viscous and/or cohesive bodily secretions, such as mucus and sputum. Disorders that can be effectively treated using the disclosed compositions and methods include cystic fibrosis (cf), endocarditis, urinary tract infections, middle-ear infections, chronic sinusitis, gingivitis, periodontal disease, bronchiectasis, chronic obstructive pulmonary disease (copd), asthma, bronchitis, neonatal meconium aspiration syndrome, smokers' cough, chronic tonsillitis, chronic vaginitis, and fungal or bacterial infections.
Breathe Easy Limited


 Stabilized pemetrexed formulation patent thumbnailStabilized pemetrexed formulation
The present invention relates to a stabilized pemetrexed formulation, and more specifically, to a stabilized pemetrexed formulation comprising acetylcysteine as an antioxidant and sodium citrate as a buffering agent. Additionally, the present invention relates to a pemetrexed formulation filled in a sealed container, comprising pemetrexed or a pharmaceutically acceptable salt thereof as an active ingredient, wherein the oxygen gas content within the headspace of the container is 3 v/v % or less..
Cj Healthcare Corporation


 Compositions and methods to prevent aav vector aggregation patent thumbnailCompositions and methods to prevent aav vector aggregation
Compositions and methods are provided for preparation of concentrated stock solutions of aav virions without aggregation. Formulations for aav preparation and storage are high ionic strength solutions (e.g.
Genzyme Corporation


 Red blood cell preservative, preservative container, manufacturing  red blood cell preservative, and blood bag system patent thumbnailRed blood cell preservative, preservative container, manufacturing red blood cell preservative, and blood bag system
A red blood cell preservative includes: a first aqueous solution containing mannitol, adenine, sodium citrate, sodium dihydrogen phosphate, and dextrose; and a second aqueous solution containing disodium phosphate, characterized in that the first aqueous solution and the second aqueous solution are mixed together after autoclave sterilization.. .
Terumo Kabushiki Kaisha


 Citrate free pharmaceutical compositions comprising anakinra patent thumbnailCitrate free pharmaceutical compositions comprising anakinra
The present invention relates to pharmaceutical compositions comprising anakinra as an active compound in the absence of sodium citrate. The said pharmaceutical compositions are useful for the treatment of il-1 mediated disorders and for decreasing nociceptive pain during such treatment..
Swedish Orphan Biovitrum Ab (publ)


Cleaning compositions including fermented fruit solutions


Described herein are cleaning compositions comprising fermented fruit solutions and builders, methods for making the same, and methods for using the same. The fermented fruit solutions can contain fruit, sugar and water.
Equator Global Limited


Method of synthesizing silica nanofibers using sound waves


A method for synthesizing silica nanofibers using sound waves is provided. The method includes providing a solution of polyvinyl pyrrolidone, adding sodium citrate and ammonium hydroxide to form a first mixture, adding a silica-based compound to the solution to form a second mixture, and sonicating the second mixture to synthesize a plurality of silica nanofibers having an average cross-sectional diameter of less than 70 nm and having a length on the order of at least several hundred microns.
Ut-battelle, Llc


Low-fat processed mozzarella cheese and food items containing same


The invention concerns a process for the production of a low-fat mozzarella comprising the steps of preparing a bulking pre-mix of dry components such as one or a mixture of rennet casein, sodium casein, milk protein concentrate and whey protein concentrate, salt, potassium sorbate and/or sorbic acid, sodium aluminium phosphate, sodium citrate, starch, skim milk powder, and stabiliser; adding said pre-mix to water at ambient temperature; raising the temperature to 80 to 85° c. Whilst stirring the mixture; and adding natural mozzarella, sequestering agent, and citric acid monohydrate or lactic acid until the mixture is smooth and homogeneous..

Compositions, uses and methods for treating or preventing dental caries


The present invention provides compositions, uses and methods thereof, for inhibiting the growth of caries-causing bacteria. The composition comprises xylitol, sodium citrate, sodium bicarbonate, anionic polymers and acceptable carrier materials.
Apollonia Health Inc.


Prophylactic/ameliorating agent for adult diseases comprising 5-aminolevulinic acid, derivative of 5-aminolevulinic acid, or salt of 5-aminolevulinic acid or the derivative of 5-aminolevulinic acid as active ingredient


A pharmaceutical composition which is different from an existing therapeutic agent of an adult disease, of a biochemical reaction-inhibiting type, and which action mechanism is to improve the basal metabolism, wherein the composition has no side effects, and does not generate drug resistance against adult disease; and a method for preventing/treating an adult disease by using the same. A composition for preventing/ameliorating an adult disease such as metabolic syndrome, diabetes, hyperlipidemia, hypertension, impaired liver function, renal failure, adiposity, erectile dysfunction, menopausal disorder, shoulder discomfort, and low back pain, comprising 5-aminolevulinic acid (ala), its derivative, or salt thereof, preferably comprising ala, its derivative, or salt thereof, and an iron compound such as sodium ferrous citrate, iron sodium citrate and iron ammonium citrate; a food or food material for preventing/ameliorating an adult disease comprising the composition; and a method for using the composition for preparing an agent for preventing/ameliorating an adult disease..

Method of synthesizing silica nanofibers using sound waves


A method for synthesizing silica nanofibers using sound waves is provided. The method includes providing a solution of polyvinyl pyrrolidone, adding sodium citrate and ammonium hydroxide to form a first mixture, adding a silica-based compound to the solution to form a second mixture, and sonicating the second mixture to synthesize a plurality of silica nanofibers having an average cross-sectional diameter of less than 70 nm and having a length on the order of at least several hundred microns.
Ut-battelle, Llc


Sodium citrate and caustic as process aids for the extraction of bitumen from mined oil sands


A process for extracting bitumen from an oil sand ore having a fines content up to about 60% and a bitumen content higher than about 6% is provided, comprising mixing the oil sand ore with heated water to form an oil sand slurry; conditioning the oil sand slurry to form a conditioned oil sand slurry; introducing a dosage of sodium citrate to the process either prior to or during the mixing step, or prior to or during the conditioning step, or both; and introducing the conditioned oil sand slurry into a separation zone to form a bitumen froth and tailings.. .
Syncrude Canada Ltd. In Trust For The Owners Of The Syncrude Project As Such Owners Exist Now And


Insect repellent surface composition


Embodiments of the invention relate to a pest-control composition comprising at least one active ingredient and at least two other ingredients; wherein the at least one active ingredient is selected from the group consisting of geraniol, nootketone, amyl cinnamaldehyde, catnip, wintergreen, carvacrol, d-limonene, orange oil, lauric acid, alpha pinene, mint, cornmint oil, lemon oil, eucalyptus, eugenol, peppermint, lemongrass oil, and terpenes; and wherein the at least two other ingredients are selected from the group consisting of 2-propanol, alcohol, ethanol, monobutyl ether, ethylene glycol, terpenes, ethoxylated alcohol, dodecanol, ammonia, soap, lauryl polyglucose, polyethylene glycol, sodium lauryl sulfate, sodium olefin sulfonate, cocamidapropyl betaine, alkylbenzene sulfonate, polyoxyethelene alkylphenol sulfate, sodium dodecyl benzene sulfonate, sodium sterate, potassium sterate, potassium myristate, tomadol, polyglyceryl sterate, glycol monosterate, potassium oleate, polyglyceryl oleate, tween, polymers, acrylic polymers, ethyl cellulous, carboxymethyl cellulose, sodium hydroxide, ammonium hydroxide, polyacrylate polymer, polyvinyl pyrolidane, lauric diethanolamine, dimethyldodecylamine oxide, aspartic acid tetrasodium salt, and sodium citrate.. .
Tyratech, Inc.


Cleaning solution


A cleaning solution is provided. The cleaning solution contains denatured alcohol, deionized water, and an organic surfactant mixture consisting of water, 2-butoxyethanol, sodium citrate, ethoxylated alcohol, and tetrapotassium pyrophosphate.

Order a batch download of a huge number of patent PDFs. Bulk PDF Downloads This is a premium service.

Translucent cosmetic composition in the form of a water-in-oil emulsion


A transparent or translucent cosmetic composition in the form of a water-in-oil emulsion is provided. The composition includes an aqueous phase at a concentration, by weight, of about 50%-90%, based upon weight of the composition.
L'oreal


System for reducing bacteria on food surfaces while extending shelf life


A synergistic system for substantially reducing surface contaminants of a food and inhibiting yeast, mold and bacteria growth in a food, beverage or food grade cosmetic preparation comprising a substantially transparent and odorless solution made from a plurality of substantially organic compounds selected from: citric acid, sodium citrate, vegetable glycerin, sea salt, potassium sorbate, decyl glucoside, calcium ascorbate, grapefruit seed extract, quillaja saponin, calcium carbonate, ascorbic acid, sodium percarbonate and sodium bisulfite, and an applicator for applying the solution to the food substance.. .
Grow Green Industries, Inc.


Catheter lock solution formulations


A liquid excipient is added to a lock solution formulation containing a lower alcohol and an anti-coagulant, antibiotic, and/or anti-microbial, such as the ethanol and tri-sodium citrate lock solution formulation, to prevent citrate from crystallizing in catheters made from silicone. The locking solution could include a liquid excipient, such as glycerol, polysorbate-20, or polyethylene glycol (peg)-400, along with a lower alcohol, such as ethanol, and an anti-coagulant, such as tri-sodium citrate, antibiotic, and/or anti-microbial..
Excelsior Medical Corporation


Process for reducing chloronitrobenzene catalyzed by platinum-nanoparticles stabilized on modified montmorillonite clay


Pt0-nanoparticles in the size range of 0 to 10 nm were prepared in-situ by impregnation of h2ptcl66h2o into the nanopores of modified montmorillonite followed by reduction with different reducing agents like ethylene glycol, sodium citrate, hydrogen, hydrazine and sodium borohydrate. The montmorillonite was modified by activation with mineral acids under controlled condition for generating desired nanopores.
Council Of Scientific & Industrial Research


Hollow silica nanomaterials and making


One embodiment of the present invention is a hollow silica nanomaterial (hsn). The hsn includes silicon dioxide (sio2) molecules which join together to form a shell.
University Of North Dakoa


Endurance sports drink utilizing tapioca starch


A sports drink mixture for making a sports drink that remains palatable while providing nutritional and energy benefits without causing negative physiological responses in the human body includes compositions of: tapioca starch, further including compositions of unprocessed and pregelatinized tapioca starch; bromelain; natural flavors; citric acid; vitamin e oil; stevia; potassium phosphate; sodium citrate; magnesium chloride; ascorbic acid; niacinamide; d-calcium pantothenate; pyridoxine hydrochloride; riboflavin; thiamine hydrochloride; folic acid; biotin; and cyanocobalamin. A sports drink includes compositions of the sports drink mixture with an aqueous liquid..

Stabilized controlled-release pharmaceutical composition comprising gliclazide


The present invention provides a stabilized controlled-release pharmaceutical composition comprising gliclazide and sodium citrate as stabilizing agent; and process for the preparation of said pharmaceutical composition.. .
Ranbaxy Laboratories Limited


Methods of using hydrogen peroxide for in-situ chemical oxidation treatment of soil and groundwater


Disclosed are methods of custom stabilization of the hydrogen peroxide used in the safe in-situ treatment of soil and groundwater. In one embodiment, disclosed is a method of in-situ chemical oxidation treatment of soil and/or groundwater wherein the hydrogen peroxide has been stabilized with carboxylate salt (e.g., sodium citrate, sodium malonate, or sodium phytate).

Anthocyanin-based colorant


1. A composition, which is an anthocyanin-based colorant composition comprising 50-90 mol-%, based on the total amount of anthocyanins, of pelargonidin-based anthocyanins, and wherein (i) >70 mol-% of all anthocyanins are acylated with at least one phenolic acid; and (ii) >20 mol-% of all anthocyanins are acylated with at least one hydroxycinnamic acid; and wherein the composition has a red color with a hue value h≧in the l*c*h* color system in the range of 10-30, measured at an l*-value of (70.0±0.1) in a 0.1 mol/l trisodium citrate dihydrate buffer at ph 3 in a 1 cm-length quartz cell using spectraflash 650 (datacolor) in transmission mode under d65 illuminant 10 deg.
Chr. Hansen A/s


Broad spectrum pharmacological composition for treatmentof various infections and diseases and methodsof use


A pharmacological composition for the treatment of bacterial and protozoal infections in a patient. The preferred pharmacological composition comprises a pharmaceutical carrier and an active composition selected from the group consisting of a) an amount of sodium oxalate and an amount of oxalic acid, b) an amount of sodium citrate and an amount of citric acid, or c) mixtures of a) and b).

Method of enhanced antibiotic activity via chemotaxis


Compositions and methods for treating infectious diseases produced by biofilms are disclosed. More specifically, the present disclosure refers to a pharmaceutical compositions which may be used for treating biofilm infections, specifically, biofilms formed by bacteria such as pseudomonas, e.

Color stable aqueous formulations containing the potassium salt of (s)-(+)-abscisic acid and methods of their use


The present invention generally relates to color stable formulations containing the potassium salt of (s)-(+)-abscisic acid, the color stabilizers sodium citrate and sodium acetate, the antimicrobial agent potassium sorbate, and do not contain an acrylic copolymer surfactant. The present invention is also directed to methods for using the present formulations in organic farming..

Stable and non-precipitating aqueous compositions containing the potassium salt of (s)-(+)-abscisic acid, and methods of their preparation and use


The present invention generally relates to aqueous compositions containing salts of (s)-(+)-abscisic acid, the surfactant atlox™ 4913, and the color stabilizers sodium citrate and sodium acetate, methods of their preparation, and methods of their agricultural use.. .

Preparation of fibrin gel for use as implant system


The present invention aims to generate a fibrin gel for cell proliferation and transport using the patient's own blood or compatible blood. The gel-preparation process consists in taking a quantity of blood from the patient, using sodium citrate as anticoagulant, separating off the citrated plasma by centrifugation, and resuspending the cells to be transported in the plasma.

Solubilized collagen fibers and producing the same


Provided are novel solubilized collagen fibers with which solubilized collagen can be obtained by instantaneous uniform dissolution in water at the time of use. The solubilized collagen fibers are formed from a solubilized collagen solid content of 66 to 87 wt %, buffer salt content of 2 to 6 wt %, water content of 10 to 22 wt %, and a residual hydrophilic organic solvent content of a trace amount of up to 6 wt % (totaling 100 wt %).

Dialysis preparation


The present invention provides a pharmaceutical composition for dialysis wherein the decline of ionized calcium concentration in an acetate-free bicarbonate dialysate comprising no acetic acid and/or sodium acetate is controlled. The present invention further provides a dialysis agent a that comprises electrolytes, citric acid and/or citrate as ph adjuster, and/or glucose, for preparation of bicarbonate dialysate; the agent a characterized by being adjusted by citric acid and/or citrate so as to keep the electrolyte ionized calcium concentration not less than 1 mmol/l in a prepared bicarbonate dialysate.

Prophylactic agent and/or therapeutic agent for sepsis


The present invention provides a sepsis therapeutic drug useful for prophylaxis and treatment of sepsis. A prophylactic agent and/or a therapeutic agent for sepsis containing 5-aminolevulinic acid (5-ala) or a derivative thereof or a pharmacologically acceptable salt of 5-ala or the derivative as an active ingredient is prepared.

Citrulline-containing beverage


The invention provides an easy-to-drink beverage that contains citrulline, wherein the generation of bad odors due to storage or heating is suppressed. In particular, the invention provides a beverage that contains citrulline, citric acid, sodium citrate, water, and one or more supplements that are saccharides, souring agents, preservatives, colorants, flavoring agents, functional ingredients, or carbon dioxide..

Thermally stable flame resistant flexible polyurethane foam


The present invention relates to a reactive formulation used to make a flame resistant flexible polyurethane foam which is particularly suited for use in under the hood vehicle applications which require sound deadening and vibration management and a process to make said foam. Said foam is particularly suitable for such applications because desirable flame resistant properties are achieved after exposure to heat over an extended period of time.

Point-of-care, medical condition screening kit


A point-of-care, screening kit for use by a heath care worker to create custom test strips for screening the bodily fluids of an individual for various, medical conditions includes: (a) a plurality of reagents (12), (b) a substrate (18) configured to: i) receive one of the reagents and react with it so as to cause it to acquire a first characteristic color, and, ii) upon the addition of the individual's bodily fluid to the substrate, acquire, as a result of the formulation of each of the reagents, a second, dichotomous characteristic color when the individual has a specific one of the various, medical conditions. This kit also includes: (c) a plurality of containers (10) having indicia (26) that are reflective of the reagent within the container and which of the various medical conditions is being screened for with the use of the container and the characteristic first and second colors which are indicative of the individual having a screened for medical condition, and (d) one of the reagents being a protein reagent that includes appropriate quantities of: water, isopropyl alcohol, citric acid monohydrate, sodium citrate iribasic monohydrate, tetrabromophenol blue and tartrazine..

Order a batch download of a huge number of patent PDFs. Bulk PDF Downloads This is a premium service.

Additive compositions for low loss wire and cable dielectric and products obtained thereby


There are disclosed additive compositions for polymer base materials, which additive compositions are comprised of blowing agent (direct gas or chemical blowing agent), thermoplastic polymer carrier for the chemical blowing agent and filler, wherein the thermoplastic polymer carrier has a melting point below the decomposition temperature of the chemical blowing agent. The chemical blowing agent can be selected from those based on hydrazine, hydrazide, or azodicarbonamide, or those based on combinations of sodium citrate/citric acid and sodium bicarbonate.

Citrate free pharmaceutical compositions comprising anakinra


The present invention relates to pharmaceutical compositions comprising anakinra as an active compound in the absence of sodium citrate. The said pharmaceutical compositions are useful for the treatment of il-1 mediated disorders and for decreasing nociceptive pain during such treatment..

Storage-stable formulation of paracetamol in aqueous solution


The present invention relates to a method for the production of a formulation that is stable to oxidation and that is based on paracetamol in an aqueous solvent, comprising the steps of (i) dissolving paracetamol in an aqueous solvent comprising an isotonic agent that is sodium chloride and a buffer agent that is sodium citrate, having a temperature between 65° c. And 95° c.

Stability and potency of hemagglutinin


The present invention relates to methods of improving the stability and maintaining the potency of recombinant hemagglutinin formulations, in particular, recombinant influenza hemagglutinin (rha). In particular, applicants have shown that the stability of rha formulations may be significantly improved by mutating cysteine residues or by formulating with a reducing agent and sodium citrate..

Tobramycin formulation


This invention provides a pharmaceutical solution formulation comprising tobramycin, water, sodium chloride and sodium citrate, wherein the formulation has a ph of 4.5-7.0 and an osmolality of 135-200 mosmol/kg.. .

High stable non-ionic n-vinyl butyrolactam iodine and preparation method thereof


The present invention relates to a preparation method of a high-stable non-ionic n-vinyl butyrolactam iodine, wherein non-ionic n-vinyl butyrolactam, iodine and at least one grinding aid are stirred at 150-800 r/min at a temperature of 50° c.-90° c. For 1 to 12 hours to prepare the high-stable non-ionic n-vinyl butyrolactam iodine, wherein the k value of the non-ionic n-vinyl butyrolactam is 32±1, the pd value of the main peak of the non-ionic n-vinyl butyrolactam is ≦1.6, the moisture content of the non-ionic n-vinyl butyrolactam is ≦2.5%, preferably, the grinding aid is selected one or several from sodium chloride, sodium citrate, sodium carbonate and sodium phosphate, the amount of the grinding aid added is 0.02 to 2% of the total amount of the non-ionic n-vinyl butyrolactam and the iodine, the non-ionic n-vinyl butyrolactam is pvp-k32, the high-stable non-ionic n-vinyl butyrolactam iodine prepared by the above mentioned method is also provided, the stability of the high-stable non-ionic n-vinyl butyrolactam iodine of the present invention is high, thereby facilitating long-term storage and use, thus the high-stable non-ionic n-vinyl butyrolactam iodine is suitable for large-scale popularization..

Flavoring systems for pharmaceutical compositions and methods of making such compositions


A flavoring system for a liquid pharmaceutical composition and pharmaceutical compositions containing such flavoring systems are disclosed. Flavoring systems of the invention include at least one sweetening agent, at least two flavored ingredients, and at least one flavor modifier selected from the group consisting of citric acid, sodium citrate, sodium chloride, and mixtures thereof.

Pharmaceutical compositions containing pemetrexed having extended storage stability


Long term storage stable pemetrexed-containing liquid pharmaceutical compositions are disclosed. The compositions can include pemetrexed or pharmaceutically acceptable salts thereof; an antioxidant selected from lipoic acid, dihydrolipoic acid, methionine and mixtures thereof; a chelating agent selected from lactobionic acid, sodium citrate, tribasic and mixtures thereof; and a pharmaceutically acceptable fluid.

Flame resistant flexible polyurethane foam


The present invention relates to a reactive formulation used to make a flame resistant flexible polyurethane foam which is particularly suited for use in under the hood vehicle applications which require sound deadening and vibration management and a process to make said foam. In particular, the flame resistant flexible polyurethane foam is made from a reactive formulation comprising an a side comprising (i) one or more organic isocyanate and a b side comprising (ii) one or more isocyanate-reactive component, (iii) a flame retardant component comprising a combination of red phosphorus, expandable graphite, and optionally sodium citrate wherein the flame retardant component does not contain ammonium polyphosphate; and (iv) one or more additional component selected from a catalyst, a blowing agent, a cell opener, a surfactant, a crosslinker, a chain extender, a filler, a colorant, a pigment, an antistatic agent, reinforcing fibers, an antioxidant, a preservative, or an acid scavenger wherein the resulting foam achieves a v-0 rating at 0.5 inch according to underwriters' laboratories standard 94 flammability test..

Synergistic, non-equilibrium aldehyde biocides


A disinfectant solution comprising: an aldehyde; a polyol; one or more acetal derivatives formed by reaction of said aldehyde with said polyol; one or more surfactants selected from the general classes anionic, cationic, or non-ionic; one or more ph buffering agents selected from the group consisting of monosodium phosphate, disodium phosphate, trisodium phosphate, sodium tetraborate, sodium bicarbonate, sodium citrate, phosphoric acid, boric acid and citric acid. The invention also relates to a process of producing the disinfectant solution, and a method of disinfecting and/or sterilizing heat sensitive medical devices comprising treating the medical devices with the disinfectant solution of the invention..

System and sorting cells


Improved flow cytometer system particularly adapted to use for sex-selected sperm sorting include enhanced sheath fluid and other strategies which minimize stress on the sperm cells, including a 2.9 percent sodium citrate sheath solution for bovine species and a hepes bovine gamete media for equine species. Improved collection systems and techniques for the process are described so that commercial applications of sperms samples as well as the resulting animals may be achieved..



Sodium Citrate topics:
  • Sodium Citrate
  • Citric Acid
  • Sodium Chloride
  • Sodium Phosphate
  • Pemetrexed
  • Antioxidant
  • Surfactant
  • Boric Acid
  • Phosphoric Acid
  • Sodium Bicarbonate
  • Sodium Chlorid
  • Flow Cytometer
  • Potassium Chloride
  • Nickel Sulfate
  • Sodium Hydroxide


  • Follow us on Twitter
    twitter icon@FreshPatents

    ###

    This listing is a sample listing of patent applications related to Sodium Citrate for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Sodium Citrate with additional patents listed. Browse our RSS directory or Search for other possible listings.


    1.0758

    5100

    0 - 1 - 102